PATRICK A. ORUWARI
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- POTOSI, MO
- NPI
- 1952396863
- Received
- $7,763 in 437 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 57 | $1,332 |
| 2024 | General payment | 48 | $807 |
| 2023 | General payment | 69 | $1,244 |
| 2022 | General payment | 45 | $937 |
| 2021 | General payment | 55 | $1,215 |
| 2020 | General payment | 63 | $749 |
| 2019 | General payment | 100 | $1,475 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 433 | $7,629 |
| Education | 4 | $133 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | HARMONY BIOSCIENCES LLC | $9 | Food and Beverage | In-kind items and services | WAKIX Drug, NARCOLEPSY | 2025 | |
| 2025-11-20 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-11-17 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-13 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-13 | HARMONY BIOSCIENCES LLC | $19 | Food and Beverage | In-kind items and services | WAKIX Drug, NARCOLEPSY | 2025 | |
| 2025-11-06 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-06 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-27 | Braeburn Inc. | $23 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-10-21 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-17 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-02 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-30 | Braeburn Inc. | $21 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-09-26 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-25 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-24 | HARMONY BIOSCIENCES LLC | $13 | Food and Beverage | In-kind items and services | WAKIX Drug, NARCOLEPSY | 2025 | |
| 2025-09-18 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-10 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-21 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-20 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-19 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-15 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-08 | HARMONY BIOSCIENCES LLC | $99 | Education | In-kind items and services | 2025 | ||
| 2025-07-31 | Collegium Pharmaceutical, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-07-31 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-30 | HARMONY BIOSCIENCES LLC | $36 | Food and Beverage | In-kind items and services | WAKIX Drug, NARCOLEPSY | 2025 | |
| 2025-07-24 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-12 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-10 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-07-09 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-18 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-12 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-10 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-05 | HARMONY BIOSCIENCES LLC | $122 | Food and Beverage | In-kind items and services | WAKIX Drug, NARCOLEPSY | 2025 | |
| 2025-05-23 | Otsuka America Pharmaceutical, Inc. | $26 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-08 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-07 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-01 | Collegium Pharmaceutical, Inc. | $21 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-04-30 | HARMONY BIOSCIENCES LLC | $10 | Food and Beverage | In-kind items and services | WAKIX Drug, NARCOLEPSY | 2025 | |
| 2025-04-25 | Supernus Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-04-18 | Lundbeck LLC | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-10 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-26 | HARMONY BIOSCIENCES LLC | $36 | Food and Beverage | In-kind items and services | WAKIX Drug, NARCOLEPSY | 2025 | |
| 2025-03-26 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-13 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-03-06 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-04 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-03 | Neurocrine BioSciences, Inc. | $120 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-31 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-30 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-28 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-24 | Janssen Pharmaceuticals, Inc | $23 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-01-21 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-16 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2024-12-20 | Neurocrine BioSciences, Inc. | $10 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-18 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-12-12 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-12-06 | Janssen Pharmaceuticals, Inc | $26 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-12-05 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-12-04 | Abbott Laboratories | $26 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE Device, Diabetes Care | 2024 | |
| 2024-12-04 | Braeburn Inc. | $20 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2024 | |
| 2024-11-26 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-21 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-07 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-10-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-24 | Neurocrine BioSciences, Inc. | $8 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-17 | Lundbeck LLC | $13 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-10 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-02 | Braeburn Inc. | $21 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2024 | |
| 2024-09-19 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-09-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-05 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-08-29 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-08-29 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-08-28 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-08-22 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-08-21 | Neurocrine BioSciences, Inc. | $8 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-08-15 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-08-15 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-24 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-06-26 | Braeburn Inc. | $16 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2024 | |
| 2024-06-20 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-06-13 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-06-12 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-05-23 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-24 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-18 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-28 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-03-19 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-15 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-02-14 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-02-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-23 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-18 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-01-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2023-12-21 | Alkermes, Inc. | $11 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-12-19 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-12-14 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $7 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-07 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-12-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-21 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-11-17 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-11-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-07 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-02 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-11-02 | Alkermes, Inc. | $1 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-10-19 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-18 | Neurocrine BioSciences, Inc. | $8 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-18 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-17 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-06 | Alkermes, Inc. | $5 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-10-05 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-09-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-09-20 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-09-20 | Neurocrine BioSciences, Inc. | $12 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-09-14 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-09-12 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-07 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-09-05 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-09-05 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-08-29 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-08-15 | Alkermes, Inc. | $14 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-08-08 | Neurocrine BioSciences, Inc. | $8 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-07-25 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-07-25 | Alkermes, Inc. | $1 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-07-18 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-14 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-06-20 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-06 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-06-06 | Alkermes, Inc. | $10 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-06-06 | Alkermes, Inc. | $2 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-06-06 | Alkermes, Inc. | $1 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-19 | Lundbeck LLC | $22 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-05-10 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-05-09 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-05 | Supernus Pharmaceuticals, Inc. | $20 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-04-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-04-19 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-04-18 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-12 | Neurocrine BioSciences, Inc. | $115 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-04-07 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-04-05 | Supernus Pharmaceuticals, Inc. | $18 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-04-04 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-03-20 | Neurocrine BioSciences, Inc. | $5 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-03-16 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-03-10 | Supernus Pharmaceuticals, Inc. | $18 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-03-09 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-03-08 | Alkermes, Inc. | $26 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-03-07 | Alkermes, Inc. | $4 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-03-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-02-21 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-02-16 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-02-15 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-10 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-02-08 | Neurocrine BioSciences, Inc. | $11 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-02-07 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-07 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-02-07 | Alkermes, Inc. | $1 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-02-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-01-10 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-05 | Supernus Pharmaceuticals, Inc. | $13 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2022-12-08 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-12-07 | Neurocrine BioSciences, Inc. | $94 | Food and Beverage | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-12-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 | |
| 2022-11-17 | Supernus Pharmaceuticals, Inc. | $24 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2022 | |
| 2022-11-15 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-11-08 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-11-03 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-11-01 | Neurocrine BioSciences, Inc. | $7 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-10-20 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-10-20 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2022 | |
| 2022-10-20 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-10-14 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2022 | |
| 2022-10-12 | Neurocrine BioSciences, Inc. | $4 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-09-22 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-09-15 | Sunovion Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-09-14 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-09-13 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-09-08 | Neurocrine BioSciences, Inc. | $8 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-08-25 | Neurocrine BioSciences, Inc. | $1 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-08-10 | Neurocrine BioSciences, Inc. | $10 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-08-05 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-08-03 | Neurocrine BioSciences, Inc. | $7 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-08-02 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2022 | |
| 2022-07-21 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-06-28 | Neurocrine BioSciences, Inc. | $99 | Food and Beverage | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2022 | |
| 2022-06-21 | Vanda Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2022 |
The latest 200 records of 437.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Potosi, MO, county Washington County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Potosi, MO | County Washington County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 2,544 | 23,470 | 6,191,814 |
| Population, 2020 census P1 | 2,538 | 23,514 | 6,154,913 |
| Median age B01002 | 34.7 | 40.7 | 39.0 |
| Under 18 B01001 | 23.6% | 23.5% | 22.3% |
| 65 and over B01001 | 18.3% | 17.9% | 17.9% |
| Households B11001 | 1,059 | 8,920 | 2,508,227 |
| Foreign born B05002 | 0.1% | 0.8% | 4.5% |
| Median household income B19013 | $39,846 | $56,043 | $70,702 |
| Median family income B19113 | $54,464 | $73,902 | $91,360 |
| Per capita income B19301 | $22,651 | $29,137 | $39,695 |
| Poverty rate B17001 | 25.0% | 17.4% | 12.6% |
| Unemployment rate B23025 | 3.7% | 3.6% | 4.0% |
| Civilian labor force B23025 | 1,136 | 9,677 | 3,120,639 |
| Mean commute (minutes) B08013 | 30.7 | 38.4 | 23.5 |
| Bachelor's degree or higher B15003 | 9.0% | 11.7% | 32.4% |
| Housing units B25001 | 1,248 | 10,734 | 2,825,287 |
| Owner-occupied B25003 | 50.0% | 78.4% | 68.1% |
| Renters B25003 | 50.0% | 21.6% | 31.9% |
| Median home value B25077 | $110,100 | $129,400 | $230,300 |
| Median gross rent B25064 | $788 | $684 | $1,033 |
| White, not Hispanic B03002 | 87.3% | 91.8% | 76.3% |
| Black B03002 | 0.8% | 1.7% | 10.9% |
| Hispanic or Latino B03002 | 1.4% | 1.1% | 5.2% |
| Asian B03002 | 0.0% | 0.1% | 2.1% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Potosi, MO.
Comments